Pulmonary hypertension due to chronic lung disease;Pulmonale Hypertonie bei chronischen Lungenerkrankungen

Deutsche Medizinische Wochenschrift

Volumn 135, Issue SUPPL. 3, 2010, Pages

  Hoeper, Marius M ^a   Andreas, S ^b   Bastian, A ^c   Claussen, M ^d   Ghofrani, H A ^e   Gorenflo, M ^f   Grohe C ^g   Gunther A ^h   Halank, M ⁱ   Hammerl, P ^b   Held, M ^j   Kruger S ^k   Lange, T J ^l   Reichenberger, F ^e   Sablotzki, A ^m   Staehler, G ⁿ   Stark, W ^o   Wirtz, H ^p   Witt, C ^q   Behr, J ^r  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Lungenfachklinik Immenhausen   (Germany)

^c Abteilung Innere Medizin   (Germany)

^d KRANKENHAUS GROSSHANSDORF   (Germany)

^e UNIVERSITY HOSPITAL GIESSEN   (Germany)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g Klinik fur Pneumologie   (Germany)

^h JUSTUS LIEBIG UNIVERSITY   (Germany)

ⁱ DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^j Missionsärztliches Institut Würzburg   (Germany)

^k UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^l UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^m Klinikum St Georg   (Germany)

ⁿ Klinik Lowenstein   (Germany)

^o Innere Medizin III   (Germany)

^p Universitätsklinikum Leipizig AöR   (Germany)

^q CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^r LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

more..

Author keywords

COPD; emphysema; pulmonary fibrosis; pulmonary hypertension

Indexed keywords

CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; ELECTROCARDIOGRAPHY; EMPHYSEMA; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; PULMONARY HYPERTENSION; CHRONIC DISEASE; COMPLICATION; CONSENSUS DEVELOPMENT; ETHICS; EVIDENCE BASED MEDICINE; GERMANY; HYPERTENSION, PULMONARY; LUNG DISEASES; MEDICAL ETHICS; MORTALITY; PRACTICE GUIDELINE; QUALITY OF LIFE;

VASODILATOR AGENT;

CHRONIC DISEASE; ETHICS, MEDICAL; EVIDENCE-BASED MEDICINE; GERMANY; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES; QUALITY OF LIFE; VASODILATOR AGENTS;

EID: 77957363680     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0030-1263318     Document Type: Conference Paper

References (41)

1. Galie N, Hoeper M M., Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 2009 34 1219-1263
2. Galie N, Hoeper M M., Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009 30 2493-2537
3. Hoeper M M., Ghofrani H A., Gorenflo M et al. Diagnostik und Therapie der pulmonalen Hypertonie: Europäische Leitlinie 2009. Pneumologie 2010 64 401-414
4. Hoeper M M., Barbera J A., Channick R N. et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol 2009 54 S85-96
5. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009 34 888-894
6. Hoeper M M. The new definition of pulmonary hypertension. Eur Respir J 2009 34 790-791
7. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008 32 1371-1385
8. Behr J, Ryu J H. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008 31 1357-1367
9. Scharf S M., Iqbal M, Keller C et al. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002 166 314-322 (Pubitemid 34864419)
10. Thabut G, Dauriat G, Stern J B. et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005 127 1531-1536 (Pubitemid 46218776)
11. Lettieri C J., Nathan S D., Barnett S D., Ahmad S, Shorr A F. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006 129 746-752
12. Shorr A F., Wainright J L., Cors C S., Lettieri C J., Nathan S D. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 2007 30 715-721 (Pubitemid 351194832)
13. Shorr A F., Helman D L., Davies D B., Nathan S D. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005 25 783-788
14. Weitzenblum E, Hirth C, Ducolone A et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981 36 752-758 (Pubitemid 12249743)
15. Hamada K, Nagai S, Tanaka S et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007 131 650-656 (Pubitemid 46446853)
16. Cottin V, Nunes H, Brillet P Y. et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005 26 586-593 (Pubitemid 41448654)
17. Cottin V, Le Pavec J, Prevot G et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010 35 105-111
18. Chaouat A, Bugnet A S., Kadaoui N et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005 172 189-194 (Pubitemid 40981192)
19. Corte T J., Wort S J., Gatzoulis M A. et al. Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension. Thorax 2009 64 883-888
20. Incalzi R A., Fuso L, De Rosa M et al. Electrocardiographic signs of chronic cor pulmonale: A negative prognostic finding in chronic obstructive pulmonary disease. Circulation 1999 99 1600-1605 (Pubitemid 29152928)
21. Tramarin R, Torbicki A, Marchandise B, Laaban J P., Morpurgo M. Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Working Group on Noninvasive Evaluation of Pulmonary Artery Pressure. European Office of the World Health Organization, Copenhagen. Eur Heart J 1991 12 103-111
22. Torbicki A, Skwarski K, Hawrylkiewicz I et al. Attempts at measuring pulmonary arterial pressure by means of Doppler echocardiography in patients with chronic lung disease. Eur Respir J 1989 2 856-860 (Pubitemid 19267627)
23. Laaban J P., Diebold B, Zelinski R et al. Noninvasive estimation of systolic pulmonary artery pressure using Doppler echocardiography in patients with chronic obstructive pulmonary disease. Chest 1989 96 1258-1262 (Pubitemid 20000817)
24. Fisher M R., Criner G J., Fishman A P. et al. Estimating pulmonary artery pressures by echocardiography in patients with emphysema. Eur Respir J 2007 30 914-921
25. Fisher M R., Forfia P R., Chamera E et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009 179 615-621
26. Arcasoy S M., Christie J D., Ferrari V A. et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003 167 735-740 (Pubitemid 36801751)
27. Leuchte H H., Baumgartner R A., Nounou M E. et al. Brain natriuretic Peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006 173 744-750
28. Hoeper M M., Lee S H., Voswinckel R et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006 48 2546-2552 (Pubitemid 44881214)
29. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985 131 493-498 (Pubitemid 15086729)
30. Agusti A G., Barbera J A., Roca J et al. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest 1990 97 268-275 (Pubitemid 20050657)
31. Barbera J A., Roger N, Roca J et al. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet 1996 347 4 36-440 (Pubitemid 26054069)
32. Simonneau G, Escourrou P, Duroux P, Lockhart A. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med 1981 304 1582-1585 (Pubitemid 11122507)
33. Domenighetti G M., Saglini V G. Short- and long-term hemodynamic effects of oral nifedipine in patients with pulmonary hypertension secondary to COPD and lung fibrosis. Deleterious effects in patients with restrictive disease. Chest 1992 102 708-714
34. Agostoni P, Doria E, Galli C, Tamborini G, Guazzi M D. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989 139 120-125 (Pubitemid 19030432)
35. Dupuis J, Hoeper M M. Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 2008 31 407-414
36. Wilkins M R., Wharton J, Grimminger F, Ghofrani H A. Phosphodiesterase inhibitors for the treatment of pulmonary hypertension. Eur Respir J 2008 32 198-209
37. Olschewski H, Gomberg-Maitland M. Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 2008 31 801-901 (Pubitemid 351945661)
38. Schulz R, Baseler G, Ghofrani H A. et al. Nocturnal periodic breathing in primary pulmonary hypertension. Eur Respir J 2002 19 658-663 (Pubitemid 34285162)
39. Stolz D, Rasch H, Linka A et al. A randomised, controlled trial of bosentan in severe COPD. Eur Respir J 2008 32 619-628
40. Blanco I, Gimeno E, Munoz P A. et al. Hemodynamic and Gas Exchange Effects of Sildenafil in Patients with COPD and Pulmonary Hypertension. Am J Respir Crit Care Med 2009 181 202-203
41. The Idiopathic Pulmonary Fibrosis Clinical Research Network. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 2010 DOI: 10.1056/NEJMoa1002110